Article Text

Download PDFPDF
Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone
  1. Alhossain Khalafallah1,2,3,
  2. Julian Grabek1,2,
  3. Robert Hayes1,
  4. Muhajir Mohamed1,2
  1. 1Department of Haematology, Launceston General Hospital, Tasmania, Australia
  2. 2Department of Medicine, Launceston General Hospital, Tasmania, Australia
  3. 3School of Human Life Sciences, University of Tasmania, Tasmania, Australia


An 85-year-old man on warfarin for atrial fibrillation presented with skin bleeding. International normalised ratio (INR) and activated partial thromboplastin time (APTT) were elevated and did not correct even after warfarin reversal with vitamin K, prothrombin complex concentrate (PCC) and fresh frozen plasma. Mixing coagulation studies with normal plasma suggested the presence of an inhibitor rather than the multiple coagulation factor deficiencies expected with warfarin. Assays of the common-pathway coagulation factors revealed factor V concentration <2% with inhibitor level elevated to 11 Bethesda units. The bleeding resolved following a course of corticosteroids. Coagulation studies and factor V level returned to normal along with resolution of the inhibitor. We report the case of the diagnostic dilemma posed and successful therapy implemented despite the limited evidence-based data being available for the treatment of this rare condition.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.